HIV and Pregnancy, Fact Sheet from http://aidsinfo.nih.gov/. Reviewed August 2015. Developed by the US Department of Health and Human Services (HHS) Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission, a Working Group of the Office of AIDS Research Advisory Council (OARAC).

has been cited by the following article:

• TITLE: A Retrospective Study of Impact of PPTCT on HIV Trends, Maternal and Perinatal Outcome

  AUTHORS: Anjali Malhotra, Sumitra Yadav

  KEYWORDS: Antiretroviral Therapy (ART), National AIDS Control Organization (NACO), Nevirapine (NVP), Prevention of Parent to Child Transmission (PPTCT)

  JOURNAL NAME: World Journal of AIDS, Vol.6 No.4, December 2, 2016

  ABSTRACT: Background: Women diagnosed with HIV/AIDS may transmit the infection to their child during pregnancy. The infection may spread during pregnancy, childbirth, or breastfeeding. However, the risk of mother-to-child transmission of HIV may be reduced by the use of HIV medications known as antiretroviral therapy (ART). Infection with HIV/AIDS is not a contraindication to pregnancy. Some women are unaware they have the disease until they become pregnant. In this case, they should begin antiretroviral therapy as soon as possible [1]. With the appropriate treatment, the risk of mother-to-child infection can be reduced to below 1% [2]. Without treatment, the risk of transmission is 15% - 45% [3]. Objective: The main aim of the study is to appreciate the declining trend of HIV in babies with HIV positive mother by implementation of PPTCT services. Methods: A retrospective study of detection of HIV positive mothers among all the antenatal patients attending OPD and including the patients coming in Emergency services and delivered in Department of Obstetrics and Gynecology at MGMMC & M. Y. Hospital, Indore, Madhya Pradesh (India) from Jan 2006 to Dec 2015 was included in the study. They were screened for HIV status and further management of all HIV positive patients.